Physical activity and sleep in adults with arthritis

October 07, 2020

A new study published in Arthritis Care & Research has examined patterns of 24-hour physical activity and sleep among patients with rheumatoid arthritis, lupus, and knee osteoarthritis.

In the 172-participant study, four profiles were apparent with differences characterized by variations in time spent sleeping (High and Low sleepers), non-ambulatory activities (High Sitters), and ambulatory activities (Balanced Activity).

Younger age, not having a job that involved a lot of sitting, and having outside walking as a habit were each associated with Balanced Activity relative to High Sitters.

Considering these profiles may be useful in efforts to help individuals with arthritis modify their activity or sleep behaviors.

"We all live our daily lives over 24 hours, and our study found that people with arthritis are likely to have one of four distinctly different patterns for how they allocate time in sleep and a variety of activities throughout their day," said lead author Lynne Feehan, PT, PhD, Department of Physical Therapy, University of British Columbia. "This suggests that a one-size-fits-all approach to supporting people with arthritis to modify their daily sleep or physical activity choices may not be appropriate."

Alison Hoens a patient partner on this study, noted, "As a patient living with rheumatoid arthritis and as a physical therapist, the findings of this study resonate strongly with me. The recognition that patients, even with similar diagnoses, are 'not all the same' speaks to the potential of tailoring support from healthcare providers to encourage healthy sleep, rest, and activity that align with a patient's habits and needs."
-end-


Wiley

Related Rheumatoid Arthritis Articles from Brightsurf:

Reducing dementia in patients with rheumatoid arthritis
The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease modifying antirheumatic drugs (DMARDs) than in patients who receive conventional synthetic DMARDs, according to a new study.

Is rheumatoid arthritis two different diseases?
While disease activity improves over time for most rheumatoid arthritis (RA) patients, long-term outcomes only improve in RA patients with autoantibodies, according to a new study published this week in PLOS Medicine by Xanthe Matthijssen of Leiden University Medical Center, Netherlands, and colleagues.

Does the Mediterranean diet protect against rheumatoid arthritis?
Previous research has demonstrated a variety of health benefits associated with the Mediterranean diet, which is rich in olive oil, cereals, fruit and vegetables, fish, and a moderate amount of dairy, meat, and wine.

Reducing corticosteroid use in rheumatoid arthritis
Is the long-term use of glucocorticoids essential in people with chronic inflammatory diseases such as rheumatoid arthritis, or can early discontinuation prevent characteristic side effects?

Rheumatoid arthritis patients under treatment with methotrexate
Patients with rheumatoid arthritis (RA) often suffer from what is referred to as interstitial lung disease (ILD).

Rheumatoid arthritis -- can its onset be delayed or prevented?
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder that leads to significant health issues as well as high treatment costs.

Disease burden in osteoarthritis is similar to rheumatoid arthritis
Osteoarthritis (OA) has traditionally been viewed as a highly prevalent but milder condition when compared with rheumatoid arthritis (RA), and some may believe that it is part of a normal aging process requiring acceptance, not treatment.

Prospect of a new treatment for rheumatoid arthritis
An international research group led by Charité -- Universitätsmedizin Berlin has completed testing a new drug to treat rheumatoid arthritis.

Can rare lymphocytes combat rheumatoid arthritis?
Immunologists at Friedrich-Alexander-Universität Erlangen-Nürnberg have demonstrated that ILC2, a group of rare lymphoid cells, play a key role in the development of inflammatory arthritis.

Rheumatoid arthritis meets precision medicine
Scientists are bringing precision medicine to rheumatoid arthritis for the first time by using genetic profiling of joint tissue to see which drugs will work for which patients, reports a new multi-site study.

Read More: Rheumatoid Arthritis News and Rheumatoid Arthritis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.